Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

Mostrar otras versiones (1)

Equitable access to vaccines is necessary to limit the global impact of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. In previous studies, we described the development of a low-cost vaccine based on a...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Domínguez, Irene, Martínez, Jose Luis, Slamanig, Stefan, Lemus, Nicholas, Liu, Yonghong, Lai, Tsoi Ying, Carreño, Juan Manuel, Singh (a), Gagandeep, Singh (b), Gagandeep, Schotsaert, Michael, Mena, Ignacio, McCroskery, Stephen, Coughlan, Lynda, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter, Sun, Weina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963686/
https://www.ncbi.nlm.nih.gov/pubmed/35350201
http://dx.doi.org/10.1101/2022.03.21.485247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963686/
https://www.ncbi.nlm.nih.gov/pubmed/35350201
http://dx.doi.org/10.1101/2022.03.21.485247

Ejemplares similares